The global apheresis equipment market is expected to reach US$ 3,528.44 Mn in 2027 from US$ 1,985.83 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027. The key factors that are driving the growth of apheresis equipment market are rising number of voluntary blood donors, increasing incidence of hematologic diseases and increasing elderly population. However, the growth of market is likely to experience restraining factors such as high cost of apheresis equipment and complications associated with apheresis. Blood diseases affects one or more parts of the body as well as total health.There are various blood diseases caused by certain genes.
Some of the common blood diseases include anemia, hemophilia, Von Willebrand disease (VWD), blood cancers such as myeloma, leukemia lymphoma and others. The rising number of these diseases demands need for blood transfusion which is expected to increase the requirement of apheresis equipment thereby bolstering the growth of the market. Anemia is the known to be the common blood disorder, and according to the National Heart, Lung, and Blood Institute, it affects more than 3 million Americans. Moreover, according to the World Health Organization (WHO), anemia affects approximately 1.62 billion people worldwide. Furthermore, according to the Centers of Disease Control and Prevention (CDC), hemophilia A affects approximately 1 in 5,000 male births. The CDC survey for 2017 reported that Von Willebrand disease (VWD), one of the most commonly occurring bleeding disorder affects up to 1% of the general population. Between 2012 and 2016, more than 14,600 men, women, and children were seen at hemophilia treatment centers for treatment of VWD. Two of the most common types of apheresis used for the removal of harmful substance from blood are cytapheresis and plasma exchange.Plasma exchange is used to treat disorders such as myasthenia gravis, thrombotic thrombocytopenic purpura, multiple sclerosis and others.
Cytapheresis is a process that removes excess number of blood cells and are used in treatment of leukemia, polycythemia and thrombocythemia. The rising incidence of hematologic diseases is thus expected to foster the growth of global apheresis equipment market over the coming years. The apheresis equipment market is segmented on the basis of product, technology, procedure, therapeutic area and end user.The market based on product segment is classified as apheresis machine and disposable apheresis kits.
Based on the technology the market is segmented as membrane separation, centrifugation.On the basis of procedure, the market is classified as erythrocytapheresis, LDL apheresis, leukapheresis, photopheresis, plasmapheresis, and plateletpheresis.
On the basis of therapeutic area, the market is segmented as renal diseases, hematology, neurology, and other applications. And on the basis of end user the market is classified as hospitals & clinics, ambulatory surgical centers, and blood donation centers.
Our reports have been used by over 10K customers, including:
The global microplate systems market size is projected to reach USD 1,170 million by 2026 from USD 927 million in 2021, at a CAGR of 4.8% from 2021 to 2026. Growth in this market is driven by the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, and the growing prevalence of diseases Microplate...
The stem cell market was valued at USD 14.7 billion in 2020, and it is expected to reach approximately USD 26.40 billion in 2026, registering a CAGR of nearly 10.24% during the forecast period, 2021-2026. The growth of the market is attributed to the rising number of clinical trials and the growing adoption of stem cell therapies globally....
The cardiac rehabilitation market is expected to reach US$ 2,865.42 million by 2028 from US$ 1,780.98 million in 2020; it is estimated to grow at a CAGR of 6.12% during 2020-2028. The growth of the market is mainly attributed to the key driving factors such as the rising incidences of cardiovascular diseases and growing adoption of tele-cardiac...
The ePRO, epatient diaries, and eCOA market was valued at US$ 1,342.92 million in 2020 and it is projected to reach US$ 4,130.35 million by 2028; it is expected to grow at a CAGR of 15.08% during 2020-2028. Increasing demand for electronic health records (EHRs) and rising use of smartphones are fueling the market growth. However, concerns...
The Vascular Embolization market was valued at approximately USD 1,381.20 million in 2020 and is expected to witness a revenue of USD 2,375.14 million in 2026, with a CAGR of 9.50% over the forecast period. The outbreak of COVID-19 impacted the vascular embolization market, as hospitals and healthcare services for non-covid indications...
The global enteral feeding formulas market was valued at USD 6,697.08 million in 2020, and it is expected to reach USD 10,069.30 million by 2026, registering a CAGR of 7%, during the forecast period. The outbreak of COVID-19 is expected to impact the enteral feeding formulas market, as good supportive care remains the cornerstone in...
175 pages •
By The Business Research Company
• May 2021
Major players in the oncology devices market are Eckert & Ziegler BEBIG, Oncura Inc, GE Healthcare, Medtronic plc, Varian Medical Systems Inc, Elekta AB, Theragenics Corporation, Accuray Incorporated, and Roche Diagnostics. The global oncology devices market is expected to grow from $96.335 billion in 2020 to $110.44 billion in 2021...
264 pages •
By The Business Research Company
• Jun 2021
Services For The Elderly And Persons With Disabilities Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global services for the elderly and persons with disabilities market as it emerges from the COVID...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
The global medical engineered materials market size is projected to reach USD 29.1 billion by 2025 from USD 15.8 billion in 2020, at a CAGR of 13.0%. This growth is attributed to the increasing healthcare expenses in emerging economies, and rising geriatric population increasing need of advanced medical technologies and devices. Also, innovations...
Medical Technology Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.